Table 2.
Patient number | Age | IBW (kg) | Duration of ventilation | Airway | PEEP | F I O 2 | Sedative | Analgetic | PaO 2 /F I O 2 at inclusion | Ramsay score | APACHE II score | Primary diagnosis |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
55 |
66 |
9 |
TC |
6 |
0.45 |
None |
Sufentanil |
228 |
4 |
12 |
Acute bowel ischemia |
2 |
48 |
70 |
2 |
ETT |
10 |
0.40 |
Propofol |
Sufentanil |
217 |
4 |
3 |
Acute peritonitis |
3 |
22 |
48 |
3 |
ETT |
12 |
0.50 |
Midazolam |
Sufentanil |
157 |
4 |
7 |
Pneumonia |
4 |
56 |
68 |
4 |
ETT |
10 |
0.40 |
None |
Sufentanil |
279 |
2 |
3 |
Pneumonia |
5 |
41 |
57 |
5 |
ETT |
10 |
0.40 |
Midazolam |
Sufentanil |
240 |
4 |
9 |
Sepsis |
6 |
19 |
75 |
14 |
TC |
10 |
0.45 |
Clonidin |
Sufentanil |
240 |
2 |
4 |
Lung contusion |
7 |
72 |
78 |
6 |
ETT |
10 |
0.45 |
None |
Sufentanil |
298 |
4 |
7 |
Perforated aortic aneurysm |
8 |
69 |
75 |
11 |
TC |
10 |
0.40 |
None |
Sufentanil |
165 |
2 |
7 |
Pneumonia |
9 |
74 |
71 |
9 |
ETT |
10 |
0.80 |
None |
Sufentanil |
165 |
3 |
7 |
Perforated aortic aneurysm |
10 |
34 |
75 |
10 |
TC |
10 |
0.45 |
Clonidin |
Sufentanil |
221 |
3 |
2 |
Lung contusion |
11 |
18 |
82 |
8 |
ETT |
12 |
0.40 |
Midazolam |
Sufentanil |
188 |
4 |
10 |
Pneumonia |
12 |
73 |
71 |
5 |
ETT |
12 |
0.40 |
None |
Sufentanil |
203 |
5 |
9 |
Lung contusion |
13 |
60 |
70 |
2 |
ETT |
8 |
0.40 |
Propofol |
Sufentanil |
248 |
2 |
7 |
Anastomotic insufficiency |
Summary counts or mean and min-max | 49.3 (18-74) | 69.7 (48-82) | 6.8 (2-14) | 4 × TC |
10 (6-12) |
0.45 (0.40-0.80) |
6 × none |
13 × sufentanil |
219 (157-298) |
3.3 (2-5) |
6.7 (2-12) |
7 × direct |
9 × ETT | 3 × midazolam |
6 × indirect | ||||||||||
2 × propofol | ||||||||||||
2 × clonidin |
IBW, ideal body weight; PEEP, positive end-expiratory pressure; FIO2, fraction of inspired oxygen; PaO2, arterial partial pressure of oxygen; APACHE II, acute physiology and chronic health evaluation. TC, tracheal cannula; ETT, endotracheal tube.